ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,291Medicare Part D Prescriptions Filled, Including Refills

Rank: 63 out of 223

$443K Total Retail Price of All Prescriptions

Rank: 80 out of 223

426 Patients Receiving at Least One Drug in Part D
85%Patients 65 Years and Older
26% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Utah
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 426 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

13% of this provider’s 426 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

2% of this provider’s 6,821 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$53 was the average price of a prescription from this provider, compared to $62 among peers.

Prescriptions per Patient

19 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Utah
LEVOTHYROXINE SODIUM 408 366 1 2
SIMVASTATIN 368 340 2 1
LISINOPRIL 367 297 3 4
HYDROCODONE-ACETAMINOPHEN 293 240 S3 4 5
AMLODIPINE BESYLATE 292 256 5 6
FUROSEMIDE 229 188 6 9
ZOLPIDEM TARTRATE 225 153 7 8
WARFARIN SODIUM 197 162 8 11
METFORMIN HCL 190 137 9 7
METOPROLOL TARTRATE 188 166 10 25
ATORVASTATIN CALCIUM 183 155 11 17
POTASSIUM CHLORIDE 183 164 11 12
OMEPRAZOLE 181 158 13 3
PRAVASTATIN SODIUM 148 140 14 15
METOPROLOL SUCCINATE 126 109 15 20
PREDNISONE 120 97 16 43
SERTRALINE HCL 118 85 17 21
GABAPENTIN 103 77 18 10
CRESTOR 99 77 19 37
FLUOXETINE HCL 87 59 20 24
HYDROCHLOROTHIAZIDE 85 82 21 13
LANTUS 79 60 22 34
ATENOLOL 78 65 23 32
CYMBALTA 75 49 24 40
ALLOPURINOL 71 71 25 28
AMITRIPTYLINE HCL 68 51 R 26 61
TRIAMTERENE-HCTZ 63 63 27 39
ALENDRONATE SODIUM 62 56 28 19
PANTOPRAZOLE SODIUM 62 57 28 45
JANUVIA 62 47 28 66
NEXIUM 59 47 31 49
SYNTHROID 59 59 31 35
TAMSULOSIN HCL 57 45 33 26
AZITHROMYCIN 54 41 34 44
LOSARTAN POTASSIUM 54 54 34 14
CLOPIDOGREL 53 47 36 56
TRAMADOL HCL 52 49 37 18
FLUTICASONE PROPIONATE 52 46 37 27
LOVASTATIN 52 52 37 51
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 25, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.